Medical News

RSS

Senesco Technologies third-quarter net loss increases to $5.28M

Senesco Technologies, Inc. today announced financial results for the three and nine months ended March 31, 2010.

18 May 2010

GCS to acquire FASA for $637 million

Grupo Casa Saba, S.A.B. de C.V., and various Chilean legal entities that are controlled by Mr. José Codner Chijner, who is the final controller of Farmacias Ahumada S.A. announced that they have reached a definitive agreement under which GCS will acquire the control of FASA in a transaction valued at approximately US$637 million, including the assumption of US$162 million in estimated net debt as of March 31, 2010.

18 May 2010

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico's Hirata for distribution of its VerifyNow System in Japan.

18 May 2010

Genesys HTA System receives FDA approval for treatment of menorrhagia

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its Genesys HTA System for the treatment of menorrhagia. The Genesys HTA System is a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia.

18 May 2010

Varian Medical Systems launches fully-integrated ProBeam proton therapy system at 2010 PT-COG

Varian Medical Systems is introducing the fully-integrated ProBeam™ proton therapy system at the 2010 Particle Therapy Co-operative Group (PT-COG) meeting here this week. The ProBeam system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians.

18 May 2010

Dane Street receives full accreditation as IRO from URAC

Dane Street today announced that it has received full accreditation as an Independent Review Organization from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the health care industry.

18 May 2010

Catalyst Pharmaceutical Partners first-quarter net loss decreases to $0.06 per basic and diluted share

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the three month period ended March 31, 2010. The Company reported a net loss of $1,045,043, or $0.06 per basic and diluted share, compared to a net loss of $3,031,201, or $0.22 per basic and diluted share, for the same period in 2009.

18 May 2010

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.

18 May 2010

Warnings about a ruined appearance is best way to reduce tanning salon visits

What's the most effective way to convince young women to cut back on their indoor tanning, a habit that hikes their risk of melanoma, the deadliest form of skin cancer, by 75 percent? Warn them that it will cause leathery, wrinkled skin.

18 May 2010

Women exposed to nickel show no elevated risk of delivering newborns with birth defects

"Women exposed to nickel show no elevated risk of delivering newborns with certain birth defects or small size at birth", says Arild Vaktskjold at the Nordic School of Public Health. "Furthermore, the women did not show an increased risk for spontaneous abortion".

18 May 2010

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

A statue commemorating the 30th anniversary of the eradication of smallpox is being unveiled today in front of the World Health Organization headquarters by the Director-General of the World Health Organization, Dr Margaret Chan.

18 May 2010

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Authors of the report, "Cellphones and Brain Tumors: 15 Reasons for Concern, Science, Spin and the Truth Behind Interphone" have released a technical analysis of the long-awaited Interphone Study published today in the International Journal of Epidemiology.

18 May 2010

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.

18 May 2010

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

ICF International awarded multi-year contract to support community action in reducing chronic disease

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a new $11.6 million multi-year contract by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, to develop a resource center for broad-scale community action to reduce chronic disease.

18 May 2010

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.

18 May 2010

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Tengion Inc. today reported its financial results for the quarter ended March 31, 2010 and provided a corporate and clinical development update.

18 May 2010

Underwriters exercise overallotment option to purchase additional 480,000 shares in Pharmasset offering

Pharmasset, Inc. announced today the underwriters of its recent stock offering have exercised their option to purchase an additional 480,000 shares of common stock. The net proceeds to Pharmasset, Inc., after deducting the underwriting discount, from the sale of these additional shares are expected to be approximately $13.2 million.

18 May 2010

Cytori's first StemSource Cell Bank sold in the U.S.

Cytori Therapeutics has sold its first StemSource Cell Bank in the United States. The StemSource Cell Bank is a suite of products that offers patients a way to store their own adipose tissue, or the stem and regenerative cells naturally occurring within their own adipose tissue, in an automated, affordable and safe manner.

18 May 2010

National Health Partners first-quarter revenues increase 29%

National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, announced today that revenue for its first fiscal quarter ended March 31, 2010 increased 29% over revenue from the prior year's first quarter. The company attributes the growth in revenue from new strategic partnerships that began during the 1st quarter.

18 May 2010

Medical News

Senesco Technologies third-quarter net loss increases to $5.28M

GCS to acquire FASA for $637 million

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Genesys HTA System receives FDA approval for treatment of menorrhagia

Varian Medical Systems launches fully-integrated ProBeam proton therapy system at 2010 PT-COG

Dane Street receives full accreditation as IRO from URAC

Catalyst Pharmaceutical Partners first-quarter net loss decreases to $0.06 per basic and diluted share

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

Warnings about a ruined appearance is best way to reduce tanning salon visits

Women exposed to nickel show no elevated risk of delivering newborns with birth defects

Statue commemorating 30th anniversary of the eradication of smallpox unveiled

Interphone Study underestimates risk of brain cancer, says International EMF Collaborative

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

International Stem Cell announces strategic alliance with TAP

ICF International awarded multi-year contract to support community action in reducing chronic disease

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

Tengion reports net loss attributable to common stockholders of $14.33 per share for first-quarter 2010

Underwriters exercise overallotment option to purchase additional 480,000 shares in Pharmasset offering

Cytori's first StemSource Cell Bank sold in the U.S.

National Health Partners first-quarter revenues increase 29%

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News